Galderma’s gel-type facial flushing treatment about to be launched in Korea

Published: 2016-03-17 16:37:58

Updated: 2016-03-17 16:38:04

A gel-type facial blushing treatment is expected to be commercialized in the domestic market.

According to the industry concerned on the 29^th, Galderma has acquired domestic approval of ‘Mirvaso,’ a self-developed gel-type ‘brimonidine’ drug. Its official launching is expected in the first half of the year.

Brimonidine, a substance that is mainly used to treat glaucoma, is excellent in safet...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.